EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Erythrocyte Fragility in Progressive Multiple Sclerosis

Carmen Jacob, Thomas E Williams, Charlotte M Stuart, Aviva Witkover, Simon Hametner, Hans Lassmann iD, Charles R M Bangham, Jeremy Chataway, Ian Galea

European Journal of Neurology · 2026

DOI: 10.1111/ene.70595 ↗

At a glance

Journal article in European Journal of Neurology, 2026. Written by Carmen Jacob and 8 co-authors. Institution: Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Major MEDLINE topics: Osmotic Fragility, Erythrocytes, Multiple Sclerosis, Chronic Progressive. Cited 2 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Multiple Sclerosis Society, National Institute for Health and Care Research, US National Multiple Sclerosis Society.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Aberrant iron homeostasis is increasingly recognized as a key pathological feature in progressive multiple sclerosis (MS). Although the source of excess brain iron remains unclear, haemoglobin is one possible source. To test this hypothesis, we conducted a case–control study to determine whether erythrocytes are more fragile in people with progressive MS (PwPMS) and examined associations between erythrocyte fragility and brain atrophy.

Methods

PwPMS and control individuals were recruited from two centres. Two measures of erythrocyte fragility were assessed at baseline: the Median Corpuscular Fragility (MCF) and haemolysis curve slope. A subset of PwPMS in one centre underwent MR imaging at the same time as osmotic fragility testing and annually for three years thereafter.

Results

A total of 174 participants were included (75 PwPMS, 99 controls), with MRI data available for 44 PwPMS. No significant differences in the MCF were observed between PwPMS and controls in either the full or age‐matched cohorts. However, the haemolysis curve slope in PwPMS was less steep than healthy controls (median PwPMS = −24.76, controls = −28.73, p = 0.017), consistent with a subpopulation of fragile erythrocytes, with a similar trend in the age‐matched subset ( p = 0.056). Erythrocyte fragility was associated with normalized whole brain volume at the time of osmotic fragility testing and up to three years thereafter.

Conclusions

Extracellular haemoglobin from lysis of an erythrocyte subpopulation may contribute to neurodegeneration in progressive MS. Further research is warranted to elucidate the interplay between erythrocyte health, inflammation and neurodegeneration, which may open avenues for novel therapeutic strategies.

Subjects

MeSH terms (MEDLINE)

Osmotic FragilityErythrocytesMultiple Sclerosis, Chronic ProgressiveHumansFemaleMaleCase-Control StudiesMiddle AgedMagnetic Resonance ImagingBrainAdultAtrophyHemolysisAged

Author keywords

erythrocytehaemoglobinhaemolysismultiple sclerosisosmotic fragility

Authors and institutions

  • Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Wessex Neurological Centre, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK.
  • Division of Neurochemistry and Neuropathology, Medical University of Vienna, Vienna, Austria.
  • Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.

ORCID profiles: Hans Lassmann

Funding

  • Multiple Sclerosis Society
  • National Institute for Health and Care Research
  • US National Multiple Sclerosis Society
  • Rosetrees Trust

Cite

APA

Jacob, C., Williams, T. E., Stuart, C. M., Witkover, A., Hametner, S., Lassmann, H., Bangham, C. R. M., Chataway, J., & Galea, I. (2026). Erythrocyte Fragility in Progressive Multiple Sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.70595

Vancouver

Jacob C, Williams TE, Stuart CM, Witkover A, Hametner S, Lassmann H, et al. Erythrocyte Fragility in Progressive Multiple Sclerosis. European Journal of Neurology. 2026. doi:10.1111/ene.70595

BibTeX
@article{Jacob2026,
  author = {Jacob, Carmen and Williams, Thomas E and Stuart, Charlotte M and Witkover, Aviva and Hametner, Simon and Lassmann, Hans and Bangham, Charles R M and Chataway, Jeremy and Galea, Ian},
  title = {Erythrocyte Fragility in Progressive Multiple Sclerosis},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70595}
}
Start for free →